Percutaneous device closure of the patent foramen ovale during pregnancy
โ Scribed by Ryan G. Schrale; Julian Ormerod; Oliver J.M. Ormerod
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 78 KB
- Volume
- 69
- Category
- Article
- ISSN
- 1522-1946
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract ## Background: Percutaneous closure of patent foramen ovale (PFO) is routinely performed with nonbiological devices, characterized by a persistent lowโgrade inflammatory response. We report our experience about PFO closure with a bioabsorbable device, BioSTARยฎ (NMT Inc, USA). ## Metho
In this study, Staubach et al. [1] report the prevalence of new atrial fibrillation after percutaneous patent foramen ovale (PFO) closure. The induction of atrial arrhythmias after the implantation of a device which could potentially affect atrial remodeling is a biologically plausible one and this